Abstract:Mohammed Alfaifi, 1, * Amit Kumar Verma, 2, * Mohammad Yahya Alshahrani, 1 Prakash C Joshi, 2 Ali G Alkhathami, 1 Irfan Ahmad, 1 Abdulrahim Refdan Hakami, 1 Mirza Masroor Ali Beg 3, 4 1 Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia; 2 Department of Zoology and Environmental Sciences, GKV, Haridwar, India; 3 Department of Medical Elementology and Toxicology, Jamia Hamdard, New Delhi, India; 4 Department of Biochemistry, Maulana Azad Medical College, New Delhi, India *These authors contributed equally to this work Correspondence: Mirza Masroor Ali Beg Department of Medical Elementology and Toxicology, Jamia Hamdard, New Delhi, India Tel +917827655616 Email mirzamasroor1986@gmail.com Background: Type 2 diabetes mellitus [T2DM] has been one of the common diseases and is characterized by increased blood glucose levels and suggested that cell-free non-coding RNAs and microRNAs (miRNAs) have been demonstrated to serve as important diagnostic/prognostic biomarkers in diabetes. Materials/Methods: The present study included clinically confirmed newly diagnosed 200 cases of T2DM and 200 healthy subjects, and all the parameters were taken care in diagnosis. Blood samples collected in plain vials were used for cell-free total RNA extraction and after that 100ng of total RNA was used to synthesize the cDNA for cell-free lncRNA H19, miRNA-29a, and miRNA-29b expression using quantitative real-time PCR method. Serum Biochemical parameters were analyzed after collection of the sample to observe the changes among T2DM cases and healthy controls. Results: It was observed that type 2 diabetic patients had decreased [0.59 fold] lncRNA H19 expression while increased miRNA-29a [5.62 fold] and miRNA-29b [5.58 fold] expression. Decreased expression of lncRNA H19 was observed to be associated with gender [p=0.004], hypertension [p< 0.0001], weight loss [p=0.02] and fatigue [p=0.02]. Increased miRNA29a expression was linked with hypertension [p< 0.0001], alcoholism [p=0.04], and smoking [p< 0.0001] as well as miRNA-29b expression was associated with hypertension [p=0.0001], weight loss [p=0.002], smoking [p=0.0002], alcoholism [p 1 fold] expression of lncRNA H19 expression was linked with miRNA-29a [p=0.005] and miRNA-29b [p< 0.0001] expression. lncRNA H19 expression showed negative correlation with miRNA-29a expression [r= − 27, p< 0.0001] and miRNA-29b [r= − 47, p< 0.0001]. Conclusion: The present study concluded that lower lncRNA H19 expression, and increased miRNA-29b, a miRNA-29b expression associated with the severity of T2DM patients. Decreased lncRNA H19 expression, and increased miRNA-29b, miRNA-29b expression observed to be interrelated with clinicopathological findings of T2DM patients could involve in pathogenesis disease. Keywords: diabetes, lncRNA, microRNA, gene expression, cell-free system

Long Non-coding RNA H19 Suppression Protects the Endothelium Against Hyperglycemic-Induced Inflammation via Inhibiting Expression of miR-29b Target Gene Vascular Endothelial Growth Factor a Through Activation of the Protein Kinase B/Endothelial Nitric Oxide Synthase Pathway

RETRACTED ARTICLE: Hsa_circ_0008360 Sponges Mir-186-5p to Target CCND2 to Modulate High Glucose-Induced Vascular Endothelial Dysfunction

Mir-29 Contributes To Normal Endothelial Function In Healthy Human Resistance Arterioles And Restores Endothelium-Dependent Vasodilation In Type 2 Diabetes

lncRNA H19 prevents endothelial–mesenchymal transition in diabetic retinopathy

Mir‐29 Contributes to Normal Endothelial Function and Can Restore It in Cardiometabolic Disorders

Abstract 15822: Mir-29 Contributes to Normal Endothelial Function in Healthy Human Resistance Arterioles and Restores Endothelium-Dependent Vasodilation in Type 2 Diabetes

Long non-coding RNA H19 improves insulin resistance in skeletal muscle by regulating heterogeneous nuclear ribonucleoprotein A1

291-LB: Long Noncoding RNA H19 Improves Insulin Resistance in Skeletal Muscle by Regulating Heterogeneous Nuclear Ribonucleoprotein A1

LncRNAH19 improves insulin resistance in skeletal muscle by regulating heterogeneous nuclear ribonucleoprotein A1

lncRNA H19 Promotes Ox-LDL-Induced Dysfunction of Human Aortic Endothelial Cells through the miR-152/VEGFA Axis

LncRNA H19 inhibition impairs endoplasmic reticulum-mitochondria contact in hepatic cells and augments gluconeogenesis by increasing VDAC1 levels

MicroRNA-29b Inhibits Diabetic Nephropathy in Db/db Mice.

H19: A Vital Long Noncoding RNA in the Treatment of Diabetes and Diabetic Complications

Abstract P124: Human Small Artery MicroRNA Expression Profiles: Changes in Type 2 Diabetes and Associations with Endothelial Function

LncRNA-H19 acts as a ceRNA to regulate HE4 expression by sponging miR-140 in human umbilical vein endothelial cells under hyperglycemia with or without α-Mangostin

Long non‐coding RNA H19 inhibition ameliorates oxygen‐glucose deprivation‐induced cell apoptosis and inflammatory cytokine expression by regulating the microRNA‐29b/SIRT1/PGC‐1α axis

Silencing long noncoding RNA-CES1P1 suppresses glomerular endothelial cell inflammation in diabetic nephropathy

Activation of AMPK/miR-181b Axis Alleviates Endothelial Dysfunction and Vascular Inflammation in Diabetic Mice

A Novel MIR503HG/miR-497-5p/CCL19 Axis Regulates High Glucose-Induced Cell Apoptosis, Inflammation, and Fibrosis in Human HK-2 Cells

LncRNA H19: a novel player in the regulation of diabetic kidney disease

Assessment of Cell-Free Long Non-Coding RNA-H19 and miRNA-29a, miRNA-29b Expression and Severity of Diabetes